King Pharmaceuticals KG LPT/ADC Agreement — Total AmTrust Reinsurance PPD
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:LiabilityforUnpaidClaimsandClaimsAdjustmentExpensePeriodIncreaseDecreaseNetofCommissionChanges.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's lpt/adc agreement — total amtrust reinsurance ppd.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's LPT/ADC agreement — total amtrust reinsurance PPD?
- King Pharmaceuticals (KG) reported LPT/ADC agreement — total amtrust reinsurance PPD of -$179K in Q1 2026.
- What does LPT/ADC agreement — total amtrust reinsurance PPD mean?
- This metric represents the net favorable or adverse development of prior period loss reserves within the Loss Portfolio Transfer and Adverse Development Cover reinsurance segment. It measures the change in estimated ultimate liabilities for claims occurring in prior periods, reflecting the accuracy of initial actuarial projections. Investors use this to assess the adequacy of reserve provisioning and the potential impact of reserve volatility on underwriting profitability.